Institutional Fund
Bain Capital Life Sciences Investors, LLC
Boston, MACIK 17030315 filings on record
Portfolio Value
$1.11B
Q1 2026
Holdings
20
Reported positions
New Buys
4
Opened this quarter
QoQ Change
-15.1%
from $1.31B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Heartflow Inc22.9%
- Newamsterdam Pharma Company21.1%
- Olema Pharmaceuticals Inc10.0%
- Savara Inc8.7%
- Pharvaris N V6.8%
- Solid Biosciences Inc6.4%
- Other24.1%
Portfolio Holdings
20 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Heartflow Inc | 10.45M | $254.20M | 22.9% | −2.00M | Reduced |
| 2 | Newamsterdam Pharma Company | 7.31M | $233.88M | 21.1% | 0 | Held |
| 3 | Olema Pharmaceuticals Inc | 7.47M | $111.43M | 10.0% | −1.04M | Reduced |
| 4 | Savara Inc | 17.60M | $96.10M | 8.7% | 0 | Held |
| 5 | Pharvaris N V | 2.68M | $75.58M | 6.8% | −126.6K | Reduced |
| 6 | Solid Biosciences Inc | 9.81M | $70.62M | 6.4% | +1.90M | Added |
| 7 | X4 Pharmaceuticals Inc | 7.97M | $32.91M | 3.0% | 0 | Held |
| 8 | Dianthus Therapeutics Inc | 362.5K | $30.42M | 2.7% | −381.1K | Reduced |
| 9 | Annexon Inc | 5.21M | $28.88M | 2.6% | −36.4K | Reduced |
| 10 | Kyverna Therapeutics Inc | 3.11M | $26.84M | 2.4% | 0 | Held |
10 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio